Citations

Showing 10 of 108081 citations.

Targeted sequencing of established and candidate colorectal cancer genes in the Colon Cancer Family Registry Cohort
(CCFR), Colon Cancer Family Registry, Rosty, Christophe , Lindor, Noralane M. , Gruber, Stephen B. , Buchanan, Daniel D. , Raskin, Leon , (CCFR), Colon Cancer Family Registry, Guo, Yan Ping , Du, Liping , Clendenning, Mark , Buchanan, Daniel D , Rosty, Christophe

Mayo Clinic

Oncotarget | June 21, 2017 | Volume: 8 | Issue: 55 | Pages: 93450-93463

10.18632/oncotarget.18596 | PMID 29212164 Get It

Getting on the same page: Communication, patient involvement and shared understanding of “decisions” in oncology
Leppin, Aaron L. , Kunneman, Marleen , Hathaway, Julie, Fernandez, Cara, Tilburt, Jon C. , Montori, Víctor M.

Mayo Clinic

Health Expectations | June 21, 2017 | Volume: 21 | Issue: 1 | Pages: 110-117

10.1111/hex.12592 | PMID 28636280 Get It

AbstractBackgroundPatients and clinicians do not often agree on whether a decision has been made about cancer care. This could be explained by factors related to communication quality and/or the type of decision being made.MethodsWe used a self‐developed coding scheme to code a random sample of 128 encounters in which patients and clinicians either agreed (n=64) or disagreed (n=64) that a cancer care decision was made and tested for associations between concordance and key communication behaviours. We also identified and characterized cancer care decisions by topic and level of patient involvement and looked for trends.ResultsWe identified 378 cancer care decisions across 128 encounters. Explicit decisions were most commonly made about topics wherein decision control could be easily delegated to a clear and present expert (eg either the patient or the clinician). Related to this, level of patient involvement varied significantly by decision topic. Explicit decisions were rarely made in an observable way about social, non‐clinical or self‐management related topics, although patients and clinicians both reported having made a cancer care decision in encounters where no decisions were observed. We found no association between communication behaviours and concordance in our sample.ConclusionsWhat counts as a “decision” in cancer care may be constructed within disparate social roles that leave many agendas unaddressed and decisions unmade. Changing the content of conversations to encourage explicit decisions about self‐management and life context‐related topics may have greater value in enabling shared understanding than promoting communication behaviours among already high‐performing communicators.
Translation repression via modulation of the cytoplasmic poly(A)-binding protein in the inflammatory response
Zhang, Xu , Chen, Xiaoli , Liu, Qiuying , Zhang, Shaojie , Hu, Wenqian , Hu, Wenqian , Zhang, Xu

Mayo Clinic

eLife | June 21, 2017 | Volume: 6 | Issue: No issue available | Pages: No page available

10.7554/elife.27786 | PMID 28635594 Get It

Gene expression is precisely regulated during the inflammatory response to control infection and limit the detrimental effects of inflammation. Here, we profiled global mRNA translation dynamics in the mouse primary macrophage-mediated inflammatory response and identified hundreds of differentially translated mRNAs. These mRNAs’ 3’UTRs have enriched binding motifs for several RNA-binding proteins, which implies extensive translational regulatory networks. We characterized one such protein, Zfp36, as a translation repressor. Using primary macrophages from a Zfp36-V5 epitope tagged knock-in mouse generated by CRISPR/Cas9-mediated genome editing, we found that the endogenous Zfp36 directly interacts with the cytoplasmic poly(A)-binding protein. Importantly, this interaction is required for the translational repression of Zfp36’s target mRNAs in resolving inflammation. Altogether, these results uncovered critical roles of translational regulations in controlling appropriate gene expression during the inflammatory response and revealed a new biologically relevant molecular mechanism of translational repression via modulating the cytoplasmic poly(A)-binding protein.
Leadership, Communication, and Negotiation Across a Diverse Workforce*
Clohisy, Denis R., Yaszemski, Michael J. , Lipman, Joanne

Mayo Clinic

Journal of Bone and Joint Surgery | June 21, 2017 | Volume: 99 | Issue: 12 | Pages: e60

10.2106/jbjs.16.00792 | PMID 28632597 Get It

Abstract: The current workforce in the United States is rapidly changing and is increasingly inclusive of individuals from a broad range of ages, ethnicities, and cultural backgrounds. Engaging and leading a diverse workforce creates great opportunities for innovation and adaptation in our evolving medical economic and clinical care delivery environment. For optimal engagement of employees and partners, orthopaedic surgeons must develop the necessary skills for executing change inside complex organizations and across teams composed of a variety of providers and skilled workers. Important skills include leadership, effective communication, and negotiation within an ever-changing employee milieu. Understanding generalizable differences between age-based generations can increase the effectiveness of one’s strategies to execute change and increase organizational performance. One of the greatest impediments to effective communication and negotiations that all leaders face is unconscious bias. For leaders, even the tiniest unconscious biases have an outsized impact. Common domains that harbor unconscious bias include sex, race, and ethnicity. Addressing unconscious bias begins with developing awareness and then deploying various tactics that might include equity in compensation, promotion, and “being heard.” Effective negotiation skills also are essential to lead a diverse workforce and develop a successful organization. The most basic goal in any negotiation should be to establish a relationship (or deepen an existing relationship) while seeking an agreement that provides win-win opportunities for all parties. To effectively achieve a win-win scenario, leaders must recognize and address their tendency to interpret others’ behaviors, values, and beliefs through the lens of their own beliefs and experiences. Finally, and fortunately, there is a set of leader attributes that transcends the generational differences and diversity that is encountered in the workplace. These attributes include integrity, credibility, effective listening, having a vision of your destination, fairness, humility, and caring.
Infantile Spasms and Injuries of Prematurity: Short-Term Treatment-Based Response and Long-Term Outcomes
Wallace, Adam, Allen, Victoria M. , Park, Kristen , Knupp, Kelly G.

Mayo Clinic

Journal of Child Neurology | June 21, 2017 | Volume: 32 | Issue: 10 | Pages: 861-866

10.1177/0883073817712587 | PMID 28635418 Get It

The association of infantile spasms and periventricular leukomalacia and/or intraventricular hemorrhage is well documented. Data regarding early treatment-based and long-term outcomes are limited. A retrospective chart review identified children with infantile spasms born prematurely (<37 weeks) with diagnoses of periventricular leukomalacia and/or intraventricular hemorrhage. Thirteen children were included. Median gestational age was 30 weeks and age of onset of infantile spasms was 8 months. Nine children had intraventricular hemorrhage, 10 had periventricular leukomalacia, and 6 children had both. Twelve of 13 children had resolution of spasms. In responders, the successful medication was adrenocorticotropic hormone (ACTH) in 7, topiramate in 3, and vigabatrin in 2. Follow-up after a median of 7.1 years found that all patients had developmental delay but only 1 had refractory epilepsy. Standard therapies (ACTH and vigabatrin) appeared to be more effective than other treatments. Developmental delay is common in children with periventricular leukomalacia / intraventricular hemorrhage and infantile spasms, but refractory epilepsy might be less frequent.
Flipped Classrooms in Graduate Medical Education: A National Survey of Residency Program Directors
Wittich, Christopher M. , Agrawal, Anoop , Wang, Amy T. , Halvorsen, Andrew J. , Mandrekar, Jayawant N. , Chaudhry, Saima , Dupras, Denise M. , Beckman, Thomas J. , Oxentenko, Amy S.

Mayo Clinic

Academic Medicine | June 21, 2017 | Volume: 93 | Issue: 3 | Pages: 471-477

10.1097/acm.0000000000001776 | PMID 28640030 Get It

Purpose To begin to quantify and understand the use of the flipped classroom (FC)—a progressive, effective, curricular model—in internal medicine (IM) education in relation to residency program and program director (PD) characteristics. Method The authors conducted a survey that included the Flipped Classroom Perception Instrument (FCPI) in 2015 regarding programs’ use and PDs’ perceptions of the FC model. Results Among the 368 IM residency programs, PDs at 227 (61.7%) responded to the survey and 206 (56.0%) completed the FCPI. Regarding how often programs used the FC model, 34 of the 206 PDs (16.5%) reported “never”; 44 (21.4%) reported “very rarely”; another 44 (21.4%) reported “somewhat rarely”; 59 (28.6%) reported “sometimes”; 16 (7.8%) reported “somewhat often”; and 9 (4.4%) reported “very often.” The mean FCPI score (standard deviation [SD]) for the in-class application factor (4.11 [0.68]) was higher (i.e., more favorable) than for the preclass activity factor (3.94 [0.65]) ( P < .001). FC perceptions (mean [SD]) were higher among younger PDs (≤ 50 years, 4.12 [0.62]; > 50 years, 3.94 [0.61]; P = .04) and women compared with men (4.28 [0.56] vs. 3.91 [0.62]; P < .001). PDs with better perceptions of FCs had higher odds of using FCs (odds ratio, 4.768; P < .001). Conclusions Most IM programs use the FC model at least to some extent, and PDs prefer the interactive in-class components over the independent preclass activities. PDs who are women and younger perceived the model more favorably.
Trends in P Value, Confidence Interval, and Power Analysis Reporting in Health Professions Education Research Reports: A Systematic Appraisal
Abbott, Eduardo , Serrano, Valentina, Rethlefsen, Melissa L. , Pandian, T.K., Naik, Nimesh D. , Pankratz, V. Shane , Cook, David A. , Abbott, Eduardo F, West, Colin P.

Mayo Clinic

Academic Medicine | June 21, 2017 | Volume: 93 | Issue: 2 | Pages: 314-323

10.1097/acm.0000000000001773 | PMID 28640032 Get It

Purpose To characterize reporting of P values, confidence intervals (CIs), and statistical power in health professions education research (HPER) through manual and computerized analysis of published research reports. Method The authors searched PubMed, Embase, and CINAHL in May 2016, for comparative research studies. For manual analysis of abstracts and main texts, they randomly sampled 250 HPER reports published in 1985, 1995, 2005, and 2015, and 100 biomedical research reports published in 1985 and 2015. Automated computerized analysis of abstracts included all HPER reports published 1970–2015. Results In the 2015 HPER sample, P values were reported in 69/100 abstracts and 94 main texts. CIs were reported in 6 abstracts and 22 main texts. Most P values (≥77%) were ≤.05. Across all years, 60/164 two-group HPER studies had ≥80% power to detect a between-group difference of 0.5 standard deviations. From 1985 to 2015, the proportion of HPER abstracts reporting a CI did not change significantly (odds ratio [OR] 2.87; 95% CI 1.04, 7.88) whereas that of main texts reporting a CI increased (OR 1.96; 95% CI 1.39, 2.78). Comparison with biomedical studies revealed similar reporting of P values, but more frequent use of CIs in biomedicine. Automated analysis of 56,440 HPER abstracts found 14,867 (26.3%) reporting a P value, 3,024 (5.4%) reporting a CI, and increased reporting of P values and CIs from 1970 to 2015. Conclusions P values are ubiquitous in HPER, CIs are rarely reported, and most studies are underpowered. Most reported P values would be considered statistically significant.
The Development of a Glucose Dehydrogenase 3D-Printed Glucose Sensor: A Proof-of-Concept Study
Adams, Anngela C. , Belle, Jeffrey T. La , La Belle, Jeffrey T, Malkoc, Aldin

Mayo Clinic

Journal of Diabetes Science and Technology | June 21, 2017 | Volume: 12 | Issue: 1 | Pages: 176-182

10.1177/1932296817715272 | PMID 28633541 Get It

This work represents a preliminary proof-of-concept design and verification of a 3D-printed glucose biosensor. The proof of concept presented is the first example of glucose dehydrogenase sensor fabricated by a 3D-printer while maintaining similar features to current lab-industry standards. The sensor was verified to detect physiological glucose concentrations between 0 and 400 mg/dL with a linear coefficient as high as .97. This study showed that it was possible to use 3D-printed technology to create a biosensor sensitive to glucose detection. As availability and functionality of 3D-printers expands, this technology has the potential to be an option for diabetes management. This preliminary study shows that the 3D-printed sensor platform holds promise for sensitive glucose detection.
Effectiveness of intra-articular therapies in osteoarthritis: a literature review
Wehling, Peter , Evans, Christopher H. , Wehling, Jana, Maixner, William, Evans, Christopher

Mayo Clinic

Therapeutic Advances in Musculoskeletal Disease | June 21, 2017 | Volume: 9 | Issue: 8 | Pages: 183-196

10.1177/1759720x17712695 | PMID 28835778 Get It

Osteoarthritis is a painful, chronic disease with widespread burden on patients, communities, health and social care systems. Conservative therapies, such as nonpharmacological interventions, systemic drug treatment and intra-articular therapies are used before resorting to surgery; nonetheless, disease control often remains inadequate. Recent advances in osteoarthritis management have aimed to provide greater variety of treatment options. Here, we summarize a targeted literature review evaluating efficacy and safety of intra-articular therapies for osteoarthritis. Injections of intra-articular therapies directly into the joint avoid conventional barriers to joint entry, increase bioavailability and lower systemic toxicity. Intra-articular corticosteroids and hyaluronic acid are established United States Food and Drug Administration (US FDA)/European Medicines Agency (EMA)-approved treatments; however, concerns exist regarding effect duration, safety, effectiveness across populations and heterogeneity. Newer therapies, such as autologous blood products and mesenchymal stem cells, are in development. Benefits of autologous blood products (e.g. platelet-rich plasma, autologous conditioned serum) include an expected improved safety profile and direct targeting of osteoarthritis-related pathophysiology. Autologous conditioned serum is cell-free and manufactured by a standardized process, whereas platelet-rich plasma composition and characteristics can vary. Currently, only limited efficacy comparisons between these biological treatments can be drawn; long-term clinical and safety studies are needed to increase the efficacy evidence base and earn consideration in treatment frameworks.
Telomere Length and Pancreatic Cancer Risk—Reply
Antwi, Samuel O. , Boardman, Lisa A., Petersen, Gloria M. , Boardman, Lisa A., Antwi, Samuel O

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | June 21, 2017 | Volume: 26 | Issue: 7 | Pages: 1158-1159

10.1158/1055-9965.epi-17-0307 | PMID 28634187 Get It